Publication | Closed Access

CXCL10 mediates CD8+ T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer

Cancer ImmunosurveillanceMedicineImmunologyColorectal CancerImmune Checkpoint InhibitorVessel NormalizationCd8+ T CellsImmunotherapyOncologyCell BiologyTumor Microenvironment